Molecule2Market is a team of clinical research professionals dedicated to advancing Australia's contribution to the research and development of innovative medical treatments.A privately owned Australian CRO (Clinical Research Organisation), we provide contract services to the pharmaceutical and biotechnology industries looking to perform clinical research in Australia and New Zealand.Combining the strength of our expertise and extensive experience, we provide high quality services across all phases of clinical research in a broad range of therapeutic areas.